Page last updated: 2024-08-18

thiophenes and Diabetic Neuropathies

thiophenes has been researched along with Diabetic Neuropathies in 97 studies

Research

Studies (97)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.03)18.7374
1990's6 (6.19)18.2507
2000's46 (47.42)29.6817
2010's44 (45.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burgess, JR; Stochelski, MA; Walters, M; Wilmanski, T1
Bouhassira, D; Cruccu, G; Freynhagen, R; Lledo, A; Schacht, A; Skljarevski, V; Tesfaye, S; Tölle, T; Wilhelm, S1
Cai, N; Moore, RA; Skljarevski, V; Tölle, TR1
Finnerup, NB1
Itoh, M; Masuda, R; Suzuki, T1
Boulton, AJ; Dickenson, AH; Tesfaye, S1
Gupta, R; Koo, JY; Levin, E; Liao, W; Wu, JJ1
Anderson, SG; Dunn, G; Heald, AH; Malipatil, NS; Roberts, H1
Aoki, T; Hamakawa, N; Matsuoka, N; Murai, N; Tamura, S; Yamamoto, H1
Kato, F; Kinoshita, J; Takahashi, Y; Utsunomiya, K; Watabe, AM1
Cappelleri, JC; Chu, BC; Johnson, BH; Johnston, SS; Shrady, G; Silverman, SL; Udall, M1
Birklein, F; Boess, FG; Happich, M; Schacht, A; Schneider, E; Wilhelm, S; Ziegler, D1
Aldington, DJ; Kalso, E; Moore, RA1
Hughes, RA; Lunn, MP; Wiffen, PJ2
Engel, CC1
Callaghan, BC; Goutman, SA; Peltier, A1
Negi, G; Sharma, SS1
Hayashizaki, Y; Takakura, S; Takasu, T; Toyoshi, T1
Forde, G; Stanos, S1
Derry, S; Gaskell, H; Moore, RA; Sultan, A1
Culebras, A; Kelly, JJ1
Holloway, RG; Noyes, K; O'Connor, AB1
Edwards, SE; Hall, JA; Lipsius, S; McCarberg, BH; Meyers, AL; Ossanna, MJ; Raskin, J; Robinson, MJ; Wasan, AD; Wernicke, JF1
Chancellor, J; Garcia-Cebrian, A; Le, TK; Löthgren, M; Monz, B; Quilici, S; Said, G; Simon, D1
Bishnoi, M; Chopra, K; Kuhad, A1
Chappell, AS; Desaiah, D; Detke, MJ; Gross, JL; Skljarevski, V; Zhang, Q; Ziegler, D1
Kempler, P1
Ameri, AA1
Acharya, N; Crucitti, A; Hall, JA; Oakes, TM; Utterback, BG; Wang, F1
Hettinger, K; Lindsay, TJ; Rodgers, BC; Savath, V1
Boulanger, L; Chen, S; Fraser, K; Police, RL; Wu, N; Zhao, Y1
Brecht, S; Crucitti, A; Nilsson, M; Wernicke, J; Yang, CR; Zhang, Q1
Cao, Z; Fowler, R; Harnett, J; Mardekian, J; Margolis, J; Sanchez, RJ; Silverman, SL1
Cheng, LL; Desaiah, D; Gao, Y; Jia, WP; Li, Q; Liu, C; Liu, ZM; Ma, JH; Ning, G; Skljarevski, V; Wen, CY; Xu, ZR; Zhang, Q; Zhang, SY; Zhou, ZG1
Sun, P; Watson, P; Zhao, Y1
Duenas, H; Gaynor, P; McCarberg, B; Shoemaker, S; Zheng, W1
Bansal, D; Bhansali, A; Chakrabarti, A; Dutta, P; Hota, D; Kaur, H1
Jolivalt, CG; Mixcoatl-Zecuatl, T1
Boulanger, L; Chen, S; Fraser, K; Wu, N; Zhao, Y; Zhao, Z1
Burke, JP; Cappelleri, JC; Halpern, R; Joshi, AV; Kulakodlu, M; Sanchez, RJ1
Fleming, KF; Wu, JJ1
Ahl, J; Irving, GA; Malcolm, SK; Risser, RC; Robinson, MJ; Skljarevski, V; Tanenberg, RJ1
Fonseca, V; Liu, J; Shi, L; Thethi, T; Zhao, Y1
Emel'ianov, VV; Galkin, VV; Nesterova, MV1
Carlos, F; Dueñas, H; Galindo-Suárez, RM; Ramírez-Gámez, J; Ramos, E1
Bernauer, M; Sun, P; Watson, P; Zhao, Y; Zhao, Z1
Arslanian, A; Best, AE; Duan, RW; Nothaft, W; Pritchett, Y; Rowbotham, MC; Stacey, BR; Zhou, Q1
Granot, M; Granovsky, Y; Khamaisi, M; Nahman-Averbuch, H; Yarnitsky, D1
Bellows, BK; Biskupiak, J; Dahal, A; Jiao, T1
Langley, P; Nalamachu, S; Pergolizzi, JV; Raffa, RB; Rodriguez, G; Taylor, R1
Aarons, L; Bueno-Burgos, L; Gueorguieva, I; Iyengar, S; Yuen, E1
Boyle, J; Coppini, DV; Eriksson, ME; Gouni, R; Gribble, L; Johnsen, S; Kerr, D1
Crowell, K; Deluca, J; Page, N1
Bae, SK; Kim, EJ; Kim, HJ; Kim, SO; Kim, YG; Lee, DH; Lee, MG; Lim, H1
Gonzales, JS; Watkin, JG; Wohlreich, MM1
Delgado, PL1
Detke, MJ; Goldstein, DJ; Iyengar, S; Lee, TC; Lu, Y1
Gahimer, J; Viktrup, L; Wernicke, JF; Wulster-Radcliffe, M; Yalcin, I1
Gayken, J; Haight, R; Westanmo, AD1
D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wernicke, JF; Wong, K1
Smith, TR1
Birnbaum, HG; Gelwicks, S; Le, TK; Mareva, MN; Robinson, RL; Rosen, A; Wu, EQ1
Russell, JW1
Desaiah, D; Perahia, DG; Pritchett, YL; Raskin, J1
D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Tran, P; Waninger, A; Wernicke, JF1
O'Connor, AB1
Ziegler, D1
Armbruster, M; Boulton, AJ; Hardy, T; Sachson, R; Shen, S1
Gahimer, J; Ossanna, MJ; Viktrup, L; Wernicke, J; Wulster-Radcliffe, M; Yalcin, I1
Chappell, AS; Desaiah, D; Hall, JA; Pritchett, YL; Robinson, MJ; Wang, F; Ziegler, D1
Terneus, W1
Kajdasz, DK; Lledó, A; Raskin, J; Wang, F; Wernicke, J1
Kempler, P; Várkonyi, T1
Kirby, M; Thor, KB; Viktrup, L1
Michel, MC1
Baglioni, P; Govindan, J; Khan, A1
Cole, BE1
Armstrong, DG; Wrobel, JS; Wu, SC1
Robinson-Papp, J; Simpson, DM1
Chappell, AS; D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wang, F; Wernicke, JF1
Beard, SM; Garcia-Cebrian, A; Le, TK; Malik, RA; McCrink, L; Monz, B1
Backonja, MM; Desaiah, D; Farrar, JT; Fishbain, DA; Iyengar, S; Jensen, TS; Kajdasz, DK; McQuay, HJ; Rowbotham, MC; Sang, CN; Ziegler, D1
Nicholson, RA; Smith, T1
Fishbain, DA; Gonzales, J; Hall, J; Mallinckrodt, C; Meyers, AL1
Mirouze, J1
Hamada, Y; Hara, T; Inukai, S; Koh, N; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H; Takeuchi, N1
Fukasawa, H; Hamada, Y; Hara, T; Hotta, N; Kakuta, H; Koh, N; Mori, K; Nakamura, J; Sakakibara, F; Wakao, T1
Agata, M; Goto, M; Inukai, S; Matsukawa, H; Naitou, A; Sato, M1
Hamada, Y; Hara, T; Hotta, N; Koh, N; Mori, K; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sakamoto, N; Wakao, T1
Hamada, Y; Hotta, N; Koh, N; Mori, K; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H; Wakao, T1
Chaya, S; Hamada, Y; Hara, T; Hotta, N; Kasuya, Y; Kato, K; Koh, N; Komori, T; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H; Takeuchi, N1
Hamada, Y; Hara, T; Hotta, N; Kamijo, M; Koh, N; Mori, K; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Wakao, T1

Reviews

27 review(s) available for thiophenes and Diabetic Neuropathies

ArticleYear
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.
    Diabetes care, 2013, Volume: 36, Issue:9

    Topics: Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes

2013
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
    The Cochrane database of systematic reviews, 2014, Jan-03, Issue:1

    Topics: Adult; Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Randomized Controlled Trials as Topic; Thiophenes

2014
Painful diabetic neuropathy.
    BMJ (Clinical research ed.), 2014, May-06, Volume: 348

    Topics: Amines; Analgesics; Analgesics, Opioid; Biopsy; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypoglycemic Agents; Pregabalin; Sensory Thresholds; Skin; Thiophenes; Touch Perception

2014
Practical management strategies for the chronic pain patient.
    The Journal of family practice, 2007, Volume: 56, Issue:8 Suppl Ho

    Topics: Administration, Cutaneous; Amines; Analgesics; Antidepressive Agents, Tricyclic; Carbamazepine; Chronic Disease; Clinical Protocols; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Monitoring; Drug Tolerance; Duloxetine Hydrochloride; Family Practice; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Middle Aged; Pain; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Substance-Related Disorders; Thiophenes; Treatment Outcome

2007
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
    BMC neurology, 2008, Aug-01, Volume: 8

    Topics: Adrenergic Uptake Inhibitors; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome

2008
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
    BMC neurology, 2009, Feb-10, Volume: 9

    Topics: Amines; Analgesics; Analysis of Variance; Bayes Theorem; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pain Measurement; Peripheral Nervous System; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome

2009
Duloxetine for treating painful neuropathy or chronic pain.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Analgesics; Chronic Disease; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Randomized Controlled Trials as Topic; Thiophenes

2009
Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
    Expert opinion on drug safety, 2010, Volume: 9, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Chronic Disease; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Polypharmacy; Randomized Controlled Trials as Topic; Thiophenes

2010
Treating diabetic peripheral neuropathic pain.
    American family physician, 2010, Jul-15, Volume: 82, Issue:2

    Topics: Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Complementary Therapies; Diabetic Neuropathies; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pain Measurement; Pregabalin; Recovery of Function; Thiophenes

2010
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
    Current medical research and opinion, 2010, Volume: 26, Issue:11

    Topics: Antidepressive Agents; Anxiety Disorders; Blood Glucose; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Glycemic Index; Humans; Hyperglycemia; Male; Middle Aged; Mood Disorders; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome

2010
Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
    International journal of clinical practice, 2011, Volume: 65, Issue:3

    Topics: Aged; Analgesics; Arthralgia; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Knee Joint; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Pain; Thiophenes; Weight Gain; Weight Loss

2011
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
    Pain practice : the official journal of World Institute of Pain, 2013, Volume: 13, Issue:3

    Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis; Thiophenes

2013
Clinical inquiry: what medications are best for diabetic neuropathic pain?
    The Journal of family practice, 2012, Volume: 61, Issue:11

    Topics: Amines; Analgesics; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Practice Guidelines as Topic; Thiophenes

2012
Common pathways of depression and pain.
    The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 12

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride

2004
Safety and adverse event profile of duloxetine.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:6

    Topics: Cytochrome P-450 Enzyme System; Depressive Disorder, Major; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Interactions; Duloxetine Hydrochloride; Half-Life; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence, Stress

2005
Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Dec-01, Volume: 62, Issue:23

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Area Under Curve; Depressive Disorder; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Formularies as Topic; Humans; Liver Failure; Randomized Controlled Trials as Topic; Renal Insufficiency; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence

2005
Duloxetine in diabetic neuropathy.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:2

    Topics: Diabetic Neuropathies; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes

2006
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    International clinical psychopharmacology, 2006, Volume: 21, Issue:6

    Topics: Analgesics; Antidepressive Agents; Chronic Disease; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Thiophenes; Treatment Outcome

2006
[Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain].
    Deutsche medizinische Wochenschrift (1946), 2006, Volume: 131 Suppl 8

    Topics: Adrenergic Uptake Inhibitors; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Pain; Quality of Life; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome

2006
Is there a place for duloxetine?
    Drug and therapeutics bulletin, 2007, Volume: 45, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder; Diabetic Neuropathies; Drug Costs; Drug Interactions; Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress

2007
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
    Drug safety, 2007, Volume: 30, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence

2007
Diabetic neuropathy: new strategies for treatment.
    Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:2

    Topics: Aldehyde Reductase; Amines; Analgesics; Anticonvulsants; Antidepressive Agents; Antioxidants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Thiamine; Thioctic Acid; Thiophenes

2008
Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
    International journal of clinical practice, 2007, Volume: 61, Issue:8

    Topics: Antidepressive Agents; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress

2007
Diabetic peripheral neuropathic pain: recognition and management.
    Pain medicine (Malden, Mass.), 2007, Volume: 8 Suppl 2

    Topics: Antidepressive Agents; Diabetic Foot; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Pain; Thiophenes

2007
Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia.
    Pain medicine (Malden, Mass.), 2007, Volume: 8 Suppl 2

    Topics: Antidepressive Agents; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic; Thiophenes

2007
Safety profile of treatment in diabetic peripheral neuropathic pain.
    Pain medicine (Malden, Mass.), 2007, Volume: 8 Suppl 2

    Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanols; Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Thiophenes; Venlafaxine Hydrochloride

2007
Review of duloxetine in the management of diabetic peripheral neuropathic pain.
    Vascular health and risk management, 2007, Volume: 3, Issue:6

    Topics: Clinical Trials as Topic; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Humans; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Thiophenes

2007

Trials

19 trial(s) available for thiophenes and Diabetic Neuropathies

ArticleYear
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
    Pain, 2013, Volume: 154, Issue:12

    Topics: Aged; Analgesics; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Internationality; Male; Middle Aged; Pain; Pregabalin; Thiophenes; Treatment Outcome

2013
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
    European journal of pain (London, England), 2014, Volume: 18, Issue:1

    Topics: Antidepressive Agents; Chronic Pain; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Fibromyalgia; Humans; Individuality; Low Back Pain; Osteoarthritis; Pain Measurement; Thiophenes; Treatment Outcome

2014
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
    Diabetes/metabolism research and reviews, 2009, Volume: 25, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Aged; Confidence Intervals; Diabetic Neuropathies; Drug Monitoring; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Thiophenes; Time Factors; Treatment Outcome

2009
Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
    Chinese medical journal, 2010, Volume: 123, Issue:22

    Topics: Adrenergic Uptake Inhibitors; Aged; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Placebos; Thiophenes; Treatment Outcome

2010
A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial.
    Diabetes care, 2011, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Amitriptyline; Cross-Over Studies; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Thiophenes; Young Adult

2011
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:7

    Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Thiophenes; Treatment Outcome

2011
[Biological age and the pain syndrome at diabetic polyneuropathy].
    Advances in gerontology = Uspekhi gerontologii, 2011, Volume: 24, Issue:2

    Topics: Adult; Aging; Amines; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Selective Serotonin Reuptake Inhibitors; Syndrome; Thiophenes; Treatment Outcome

2011
Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain.
    Pain, 2012, Volume: 153, Issue:4

    Topics: Aged; Azabicyclo Compounds; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Nicotinic Agonists; Pain Measurement; Pyridines; Receptors, Nicotinic; Thiophenes; Treatment Outcome

2012
Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy.
    Pain, 2012, Volume: 153, Issue:6

    Topics: Aged; Analgesics; Conditioning, Psychological; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Pain Threshold; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Thiophenes

2012
Population pharmacokinetic/pharmacodynamic models for duloxetine in the treatment of diabetic peripheral neuropathic pain.
    European journal of pain (London, England), 2013, Volume: 17, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Analgesics; Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Nonlinear Dynamics; Pain Measurement; Patient Dropouts; Sex Factors; Socioeconomic Factors; Thiophenes; Young Adult

2013
Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
    Diabetes care, 2012, Volume: 35, Issue:12

    Topics: Aged; Amitriptyline; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Pregabalin; Quality of Life; Sleep; Thiophenes; Treatment Outcome

2012
Duloxetine vs. placebo in patients with painful diabetic neuropathy.
    Pain, 2005, Volume: 116, Issue:1-2

    Topics: Aged; Demography; Depression; Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain Measurement; Personality Inventory; Placebos; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome

2005
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
    Journal of palliative medicine, 2006, Volume: 9, Issue:1

    Topics: Amines; Amitriptyline; Analysis of Variance; Cyclohexanecarboxylic Acids; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride

2006
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    The journal of pain, 2006, Volume: 7, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Aged; Amines; Amitriptyline; Analgesia; Analgesics; Brain; Cohort Studies; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Norepinephrine; Pain Measurement; Pain Threshold; Placebo Effect; Serotonin; Thiophenes; Treatment Outcome; United States; Venlafaxine Hydrochloride

2006
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Neurology, 2006, Oct-24, Volume: 67, Issue:8

    Topics: Acetaminophen; Adrenergic Uptake Inhibitors; Aged; Analgesics, Non-Narcotic; Diabetic Neuropathies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Norepinephrine; Pain; Palliative Care; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome

2006
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
    Diabetes care, 2007, Volume: 30, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Aged; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Humans; Least-Squares Analysis; Middle Aged; Neuritis; Pain Measurement; Placebos; Racial Groups; Safety; Thiophenes; Treatment Outcome

2007
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
    Pain medicine (Malden, Mass.), 2007, Volume: 8, Issue:6

    Topics: Acetaminophen; Amitriptyline; Analgesics; Carbamazepine; Diabetes Complications; Diabetic Neuropathies; Diclofenac; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Lipids; Male; Meloxicam; Middle Aged; Neuralgia; Pentoxifylline; Selective Serotonin Reuptake Inhibitors; Thiamine; Thiazines; Thiazoles; Thioctic Acid; Thiophenes; Time; Vitamin B 12

2007
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
    Clinical therapeutics, 2007, Volume: 29 Suppl

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuralgia; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Thiophenes

2007
Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
    Agents and actions. Supplements, 1984, Volume: 15

    Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Anticoagulants; Brain Ischemia; Clinical Trials as Topic; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Electrocardiography; Fluorescein Angiography; Follow-Up Studies; Humans; Middle Aged; Patient Compliance; Platelet Aggregation; Thiophenes; Ticlopidine

1984

Other Studies

51 other study(ies) available for thiophenes and Diabetic Neuropathies

ArticleYear
D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathy.
    Redox biology, 2019, Volume: 21

    Topics: Antioxidants; Cell Line, Tumor; Cell Survival; Dehydroepiandrosterone; Diabetic Neuropathies; Glutathione; Glutathione Transferase; Glycation End Products, Advanced; Humans; Models, Biological; Neurites; Oxidative Stress; Thiones; Thiophenes

2019
Add-on therapy: when two are not better than one.
    Pain, 2013, Volume: 154, Issue:12

    Topics: Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Pain; Pregabalin; Thiophenes

2013
[Duloxetine for chronic pain management: pharmacology and clinical use].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Chronic Pain; Depression; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Thiophenes

2013
Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient.
    Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:10

    Topics: Adalimumab; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Biological Products; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Psoriasis; Thiophenes; Young Adult

2013
Socioeconomic deprivation independently predicts symptomatic painful diabetic neuropathy in type 1 diabetes.
    Primary care diabetes, 2014, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Analgesics; Biomarkers; Body Mass Index; Chi-Square Distribution; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Duloxetine Hydrochloride; England; Female; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Poverty; Prevalence; Risk Assessment; Risk Factors; Severity of Illness Index; Thiophenes; Young Adult

2014
AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy.
    Neuropharmacology, 2014, Volume: 79

    Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibroblast Growth Factor 2; Ganglia, Spinal; Hyperalgesia; Insulin-Like Growth Factor I; Male; Morpholines; Neural Conduction; Neurotransmitter Uptake Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spinal Cord; Streptozocin; Thiophenes; Time Factors

2014
Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
    Molecular pain, 2013, Nov-27, Volume: 9

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Duloxetine Hydrochloride; Male; Norepinephrine; Rats; Selective Serotonin Reuptake Inhibitors; Thiophenes

2013
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Dec-15, Volume: 70, Issue:24

    Topics: Aged; Analgesics; Cohort Studies; Databases, Factual; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Middle Aged; Pregabalin; Retrospective Studies; Thiophenes; United States

2013
Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study.
    The Clinical journal of pain, 2014, Volume: 30, Issue:10

    Topics: Aged; Amines; Analgesics; Chi-Square Distribution; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Germany; Health Surveys; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Prospective Studies; Thiophenes; Treatment Outcome

2014
Drugs for neuropathic pain.
    BMJ (Clinical research ed.), 2013, Dec-19, Volume: 347

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pregabalin; Thiophenes; Treatment Outcome

2013
ACP Journal Club. Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events.
    Annals of internal medicine, 2014, Apr-15, Volume: 160, Issue:8

    Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Thiophenes

2014
Inhibition of IκB kinase (IKK) protects against peripheral nerve dysfunction of experimental diabetes.
    Molecular neurobiology, 2015, Volume: 51, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; I-kappa B Kinase; Male; Neural Conduction; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Thiophenes

2015
Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats.
    Life sciences, 2016, Feb-15, Volume: 147

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Progression; Glucosides; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes

2016
Sleep disorders and neuromuscular diseases.
    Reviews in neurological diseases, 2008,Summer, Volume: 5, Issue:3

    Topics: Administration, Cutaneous; Brain Injuries; Continuous Positive Airway Pressure; Copper; Diabetic Neuropathies; Dopamine Agonists; Humans; Ischemic Attack, Transient; Myasthenia Gravis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Restless Legs Syndrome; Sleep Apnea Syndromes; Sleep Wake Disorders; Stroke; Tetrahydronaphthalenes; Thiophenes

2008
A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
    PharmacoEconomics, 2008, Volume: 26, Issue:12

    Topics: Amines; Analgesics; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Desipramine; Diabetic Neuropathies; Duloxetine Hydrochloride; Economics, Pharmaceutical; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Pregabalin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Thiophenes

2008
Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
    Current drug safety, 2009, Volume: 4, Issue:1

    Topics: Age Factors; Aged; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome

2009
Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.
    Indian journal of experimental biology, 2009, Volume: 47, Issue:3

    Topics: Adenosine; Animals; Cerebral Cortex; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Pain Measurement; Pain Threshold; Selective Serotonin Reuptake Inhibitors; Streptozocin; Thiophenes; Touch

2009
[Treatment of neuropathies].
    Orvosi hetilap, 2010, Jan-10, Volume: 151, Issue:2

    Topics: Adjuvants, Immunologic; Adrenergic Uptake Inhibitors; Amines; Analgesics; Antioxidants; Capsaicin; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Polyneuropathies; Pregabalin; Sensory System Agents; Thiamine; Thioctic Acid; Thiophenes

2010
[Expel the fear of pain. Breaking of chronicity by re-learning].
    MMW Fortschritte der Medizin, 2009, Dec-10, Volume: 151, Issue:51-52

    Topics: Analgesics; Clinical Trials as Topic; Diabetic Neuropathies; Duloxetine Hydrochloride; Fear; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Treatment Outcome

2009
Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Current medical research and opinion, 2010, Volume: 26, Issue:9

    Topics: Adolescent; Adult; Analgesics; Analgesics, Opioid; Diabetic Neuropathies; Drug Substitution; Duloxetine Hydrochloride; Female; Health Care Costs; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Young Adult

2010
Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
    Journal of medical economics, 2010, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Age Factors; Analgesics; Comorbidity; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Services; Humans; Insurance Claim Review; Male; Middle Aged; Pain; Pregabalin; Sex Factors; Socioeconomic Factors; Thiophenes; Young Adult

2010
Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Current medical research and opinion, 2011, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Analgesics; Cohort Studies; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Neuralgia; Pregabalin; Retrospective Studies; Thiophenes; Young Adult

2011
A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
    British journal of pharmacology, 2011, Volume: 164, Issue:1

    Topics: Amphetamines; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Hyperalgesia; Ketanserin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Thiophenes

2011
Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
    Journal of medical economics, 2011, Volume: 14, Issue:4

    Topics: Analgesics; Comorbidity; Costs and Cost Analysis; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Health Services; Humans; Insurance Claim Review; Male; Middle Aged; Pain; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Socioeconomic Factors; Thiophenes; United States

2011
Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Pain practice : the official journal of World Institute of Pain, 2012, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics; Cohort Studies; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Health Care Costs; Health Services; Humans; Male; Managed Care Programs; Middle Aged; Pregabalin; Thiophenes; United States

2012
Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy.
    Cutis, 2011, Volume: 87, Issue:5

    Topics: Adalimumab; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Psoriasis; Selective Serotonin Reuptake Inhibitors; Thiophenes; Young Adult

2011
Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
    Pain practice : the official journal of World Institute of Pain, 2012, Volume: 12, Issue:5

    Topics: Aged; Analgesics; Antidepressive Agents; Cohort Studies; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Thiophenes; Veterans

2012
Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.
    Journal of medical economics, 2012, Volume: 15, Issue:2

    Topics: Amines; Analgesics; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Dopamine Uptake Inhibitors; Drug Costs; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Mexico; Pregabalin; Thiophenes

2012
Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.
    Pain practice : the official journal of World Institute of Pain, 2012, Volume: 12, Issue:8

    Topics: Analgesics; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Pregabalin; Thiophenes

2012
A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.
    Journal of pain & palliative care pharmacotherapy, 2012, Volume: 26, Issue:2

    Topics: Analgesics; Antidepressive Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Approval; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Models, Economic; Pregabalin; Quality-Adjusted Life Years; Thiophenes; United States; United States Food and Drug Administration

2012
Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
    Journal of pharmaceutical sciences, 2003, Volume: 92, Issue:5

    Topics: Administration, Oral; Animals; Area Under Curve; Bile; Chromatography, High Pressure Liquid; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Stability; Gastric Juice; Gastric Mucosa; Half-Life; Injections, Intravenous; Intestinal Mucosa; Liver; Male; Peripheral Nervous System Agents; Rats; Rats, Sprague-Dawley; Thiophenes; Time Factors; Tissue Distribution

2003
Duloxetine's role in the treatment of depression and associated painful physical symptoms.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:7

    Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Pain; Pain Measurement; Thiophenes; Treatment Outcome

2004
Molecule of the month. Duloxetine hydrochloride.
    Drug news & perspectives, 2004, Volume: 17, Issue:9

    Topics: Adult; Diabetic Neuropathies; Drug Administration Schedule; Duloxetine Hydrochloride; Fibromyalgia; Humans; Multicenter Studies as Topic; Thiophenes; Time Factors

2004
[Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression].
    Krankenpflege Journal, 2004, Volume: 42, Issue:7-10

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depressive Disorder, Major; Diabetic Neuropathies; Drug Approval; Duloxetine Hydrochloride; Europe; Humans; Pharmacy and Therapeutics Committee; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence, Stress

2004
Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Nature clinical practice. Neurology, 2006, Volume: 2, Issue:1

    Topics: Antidepressive Agents; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Pain; Pain Measurement; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome

2006
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    The journal of pain, 2006, Volume: 7, Issue:11

    Topics: Antidepressive Agents; Cost-Benefit Analysis; Diabetic Neuropathies; Drug Costs; Duloxetine Hydrochloride; Humans; Pain; Thiophenes

2006
Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects.
    Prescrire international, 2006, Volume: 15, Issue:85

    Topics: Adult; Depression; Diabetic Neuropathies; European Union; Female; Fibromyalgia; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome

2006
Does treatment with duloxetine for neuropathic pain impact glycemic control?
    Diabetes care, 2007, Volume: 30, Issue:1

    Topics: Adult; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Neuritis; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes

2007
A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
    Current medical research and opinion, 2007, Volume: 23, Issue:1

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anxiety Disorders; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Thiophenes; United States; Urinary Incontinence, Stress

2007
Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Journal of pain & palliative care pharmacotherapy, 2007, Volume: 21, Issue:1

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia; Pain; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes

2007
Duloxetine--three birds with one stone?
    International journal of clinical practice, 2007, Volume: 61, Issue:8

    Topics: Antidepressive Agents; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence, Stress

2007
Career lifetime advances and key developments: diabetes.
    Clinical medicine (London, England), 2007, Volume: 7, Issue:3

    Topics: Amines; Amitriptyline; Analgesics; Antidepressive Agents; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Thiophenes

2007
Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
    Current medical research and opinion, 2008, Volume: 24, Issue:2

    Topics: Amines; Amitriptyline; Antidepressive Agents; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Models, Econometric; Paclitaxel; Pain Measurement; Prospective Studies; Quality-Adjusted Life Years; Sickness Impact Profile; Thiophenes; Treatment Outcome; United Kingdom

2008
Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Journal of pain and symptom management, 2008, Volume: 36, Issue:6

    Topics: Antidepressive Agents; Chronic Disease; Comorbidity; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Incidence; Male; Middle Aged; Pain; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Thiophenes; Treatment Outcome; United States

2008
An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    The Journal of laboratory and clinical medicine, 1995, Volume: 126, Issue:6

    Topics: Adenosine Diphosphate; Aldehyde Reductase; Ampholyte Mixtures; Animals; Blood Glucose; Blood Platelets; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Male; Neural Conduction; Platelet Aggregation; Polymers; Rats; Rats, Wistar; Sciatic Nerve; Streptozocin; Tetrazoles; Thiophenes

1995
Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Diabetes research and clinical practice, 1995, Volume: 27, Issue:2

    Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocytes; Fructose; Glucose; Inositol; Male; Motor Neurons; Neural Conduction; Peripheral Nerves; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Regression Analysis; Sciatic Nerve; Sorbitol; Tail; Tetrazoles; Thiophenes; Time Factors

1995
Characterization of a novel aldose reductase inhibitor, TAT, and its effects on streptozotocin-induced diabetic neuropathy in rats.
    Japanese journal of pharmacology, 1993, Volume: 61, Issue:3

    Topics: Aldehyde Reductase; Animals; Diabetic Neuropathies; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Neural Conduction; Rabbits; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sorbitol; Sugar Alcohols; Tetrazoles; Thiophenes

1993
Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:1

    Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Carbohydrate Metabolism; Cardiotonic Agents; Carnitine; Cauda Equina; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrocardiography; Enzyme Inhibitors; Heart Conduction System; Lipids; Male; Motor Neurons; Neural Conduction; Rats; Rats, Wistar; Sciatic Nerve; Tetrazoles; Thiophenes

1996
Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TAT.
    Life sciences, 1997, Volume: 60, Issue:21

    Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Enzyme Inhibitors; Insulin; Lipids; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymers; Rats; Regional Blood Flow; Sciatic Nerve; Sucrose; Tetrazoles; Thiophenes

1997
Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3

    Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Hemodynamics; Male; Neural Conduction; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tetrazoles; Thiophenes

1998
Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats.
    Diabetes research and clinical practice, 2001, Volume: 51, Issue:1

    Topics: 2,3-Diphosphoglycerate; Aldehyde Reductase; Animals; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dietary Sucrose; Enzyme Inhibitors; Erythrocytes; Humans; Hyperglycemia; Male; Neural Conduction; Platelet Aggregation; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Regional Blood Flow; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Thiophenes

2001